Pharmacokinetics and effect on caffeine metabolism of the proton pump inhibitors, omeprazole, lansoprazole, and pantoprazole.
暂无分享,去创建一个
T. Andersson | A. Walan | K. Röhss | T Andersson | J Holmberg | K Röhss | A Walan | J. Holmberg
[1] L. Benet,et al. Pharmacokinetics‐‐a relevant factor for the choice of a drug? , 1994, Alimentary Pharmacology and Therapeutics.
[2] B K Tang,et al. Variability in caffeine metabolism , 1983, Clinical pharmacology and therapeutics.
[3] S. Spielberg,et al. A urinary metabolite ratio that reflects systemic caffeine clearance , 1987, Clinical pharmacology and therapeutics.
[4] C. Alm,et al. S‐mephenytoin hydroxylation phenotypes in a Swedish population determined after coadministration with debrisoquin , 1989, Clinical pharmacology and therapeutics.
[5] C. Bonfils,et al. Oxidative metabolism of lansoprazole by human liver cytochromes P450. , 1995, Molecular pharmacology.
[6] P. Guzelian,et al. Characterization of human liver cytochromes P-450 involved in theophylline metabolism. , 1992, Drug metabolism and disposition: the biological fate of chemicals.
[7] I. Roots,et al. Specific and dose‐dependent enzyme induction by omeprazole in human beings , 1994, Hepatology.
[8] E. Perucca,et al. Omeprazole Does Not Enhance the Metabolism of Phenacetin, a Marker of CYP1A2 Activity, in Healthy Volunteers , 1994, Therapeutic drug monitoring.
[9] P. Lundborg,et al. Effect of omeprazole treatment on diazepam plasma levels in slow versus normal rapid metabolizers of omeprazole , 1990, Clinical pharmacology and therapeutics.
[10] T. Andersson,et al. The Pharmacokinetics of Single and Repeated Once-Daily Doses of 10, 20 and 40mg Omeprazole as Enteric-Coated Granules , 1991 .
[11] L. Bertilsson,et al. Slow omeprazole metabolizers are also poor S-mephenytoin hydroxylators. , 1990, Therapeutic drug monitoring.
[12] S. Kitareewan,et al. Evidence that CYP2C19 is the major (S)-mephenytoin 4'-hydroxylase in humans. , 1994, Biochemistry.
[13] T. Kamataki,et al. Oxidative metabolism of omeprazole in human liver microsomes: cosegregation with S-mephenytoin 4'-hydroxylation. , 1993, The Journal of pharmacology and experimental therapeutics.
[14] P. Lagerström,et al. Determination of omeprazole and metabolites in plasma and urine by liquid chromatography. , 1984, Journal of chromatography.
[15] R. Bergstrand,et al. Omeprazole treatment does not affect the metabolism of caffeine. , 1991, Gastroenterology.
[16] M. J. Coon,et al. The P450 superfamily: update on new sequences, gene mapping, accession numbers, early trivial names of enzymes, and nomenclature. , 1993, DNA and cell biology.
[17] L. Kaminsky,et al. Characterization of human cytochromes P450 involved in theophylline 8-hydroxylation. , 1995, Biochemical pharmacology.
[18] I. Roots,et al. Accelerated caffeine metabolism after omeprazole treatment is indicated by urinary metabolite ratios: Coincidence with plasma clearance and breath test , 1994, Clinical pharmacology and therapeutics.
[19] J. Domergue,et al. Omeprazole and lansoprazole are mixed inducers of CYP1A and CYP3A in human hepatocytes in primary culture. , 1994, The Journal of pharmacology and experimental therapeutics.
[20] G. Granneman,et al. Pharmacokinetic Interaction Between Lansoprazole and Theophylline , 1995, Therapeutic drug monitoring.
[21] T. Andersson. Pharmacokinetics, Metabolism and Interactions of Acid Pump Inhibitors , 1996, Clinical pharmacokinetics.
[22] J. Brockmöller,et al. Increase of cytochrome P450IA2 activity by omeprazole: Evidence by the 13C‐[N‐3‐methyl]‐caffeine breath test in poor and extensive metabolizers of S‐mephenytoin , 1992, Clinical pharmacology and therapeutics.
[23] R. Gugler,et al. Drugs other than H2-receptor antagonists as clinically important inhibitors of drug metabolism in vivo. , 1987, Pharmacology & therapeutics.
[24] G. Sachs,et al. The continuing development of proton pump inhibitors with particular reference to pantoprazole , 1995, Alimentary pharmacology & therapeutics.
[25] A. Blum,et al. Effects of omeprazole and lansoprazole on 24-hour intragastric pH in Helicobacter pylori-positive volunteers. , 1994, Scandinavian journal of gastroenterology.
[26] J. Miners,et al. Identification of human liver cytochrome P450 isoforms mediating omeprazole metabolism. , 1993, British journal of clinical pharmacology.
[27] W. Wurst,et al. Lack of influence of pantoprazole on the disposition kinetics of theophylline in man. , 1991, International journal of clinical pharmacology, therapy, and toxicology.
[28] J. Miners,et al. Characterisation of theophylline metabolism by human liver microsomes. Inhibition and immunochemical studies. , 1988, Biochemical pharmacology.
[29] G. Tucker,et al. The interaction of proton pump inhibitors with cytochromes P450. , 1994, Alimentary pharmacology & therapeutics.